Bristol-Myers Squibb Company
Substituted benzofuran compounds for the treatment of hepatitis C

Abstract:

Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV: ##STR00001##